59
Participants
Start Date
July 21, 2020
Primary Completion Date
February 10, 2023
Study Completion Date
February 10, 2023
Remdesivir
Administered as an intravenous infusion
Hospital Universitari Vall D'Hebron, Barcelona
Hospital Sant Joan de Déu, Esplugues de Llobregat
NYC Health + Hospitals/Jacobi Medical Center, The Bronx
Montefiore Medical Center, The Bronx
Northwell Health-Cohen Children's Medical Center, New Hyde Park
Hospital Clínico Universitario de Santiago, Santiago de Compostela
Lehigh Valley Hospital/Lehigh Valley Health Network (LVH/LVHN), Allentown
St. Christopher's Hospital for Children, Philadelphia
Johns Hopkins Children's Center, Baltimore
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Carolinas Medical Center-Levine Children's Hospital, Charlotte
Tampa General Hospital (Inpatient Visits), Tampa
Azienda Ospedaliera di Padova - Dipartimento Salute della Donna e del Bambino, Padua
Children's Hospital of Alabama, Birmingham
Norton Children's Hospital, Louisville
UO Clinica Pediatrica, Ospedale Pietro Barilla - AOU di Parma, Parma
Spectrum Health/Helen De Vos Children's Hospital, Grand Rapids
Azienda Ospedaliero Universitaria Meyer, Florence
Children's Minnesota, Minneapolis
Ann & Robert H. Lurie Children's Hospital, Chicago
Tulane University School of Medicine, New Orleans
Children's Medical Center, Dallas
Texas Children's Hospital, Houston
Children's Hospital Los Angeles, Los Angeles
Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles
Rady Children's Hospital San Diego, San Diego
Valley Children's Hospital, Madera
UC Davis Medical center, Sacramento
Boston Children's Hospital, Boston
Alder Hey Children's NHS Foundation Trust, Liverpool
Lead Sponsor
Gilead Sciences
INDUSTRY